Key result
Human microRNA-499c promotes myofibril formation and boosts cardiac marker expression in mutant hearts.
Why the study?
A recessive mutation in axolotl embryos causes failure of normal heart development with absent organized myofibrils and nonbeating hearts, motivating investigation of factors promoting cardiac development.
Does microRNA-499c promote myofibril formation and rescue cardiac development in mutant axolotl embryos?
Does microRNA-499c promote myofibril formation and rescue cardiac development in mutant axolotl embryos?
A newly identified human microRNA, microRNA-499c, promotes myofibril formation and rescues cardiac development in a mutant axolotl model.
Answers are grounded in this paper and cite their sources.
Human RNA #291 may promote myofibrillogenesis in developmental models; leaves open any role in human congenital heart disease.
BACKGROUND: A recessive mutation "c" in the Mexican axolotl, Ambystoma mexicanum, results in the failure of normal heart development. In homozygous recessive embryos, the hearts do not have organized myofibrils and fail to beat. In our previous studies, we identified a noncoding Myofibril-Inducing RNA (MIR) from axolotls which promotes myofibril formation and rescues heart development. RESULTS: We randomly cloned RNAs from fetal human heart. RNA from clone #291 promoted myofibril formation and induced heart development of mutant axolotls in organ culture. This RNA induced expression of cardiac markers in mutant hearts: tropomyosin, troponin and α-syntrophin. This cloned RNA matches in partial sequence alignment to human microRNA-499a and b, although it differs in length. We have concluded that this cloned RNA is unique in its length, but is still related to the microRNA-499 family. We have named this unique RNA, microRNA-499c. Thus, we will refer to this RNA derived from clone #291 as microRNA-499c throughout the rest of the paper. CONCLUSIONS: This new form, microRNA-499c, plays an important role in cardiac development.
No takes yet. Share an insight, caveat, or question.
Kochegarov et al. (2013) studied Cardiac development failure in mutant axolotl embryos. microRNA-499c vs. Untreated mutant hearts (lipofectin only) was evaluated on Expression of cardiac markers (tropomyosin, troponin T, α-syntrophin) and myofibril formation (p=<0.05). Human-derived microRNA-499c promoted myofibril formation and significantly increased the expression of cardiac markers in mutant axolotl hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: